Sex-Based Differences in SGLT2i and GLP-1RA Use and Mortality in T2DM with Atherosclerotic Cardiovascular Disease

<b>Background</b>: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) remain underused in routine practice, particularly among women. <b>Aim</b>: This study evaluated gender differences in mortality among patients with T2DM and established athe...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hana Vaknin-Assa, Ammie Wolf, Ranin Hilu, Ela Giladi, Mustafa Gabarin, Ilya Losin, Yoav Arnson, David Pereg, Abid Assali, Ziad Arow
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2026-02-01
Ráidu:	Biomedicines
Fáttát:	sodium-glucose cotransporter-2 inhibitor (SGLT2i) glucagon-like peptide-1 receptor agonist (GLP-1RA) type 2 diabetes mellitus (T2DM) atherosclerotic cardiovascular disease (ASCVD)
Liŋkkat:	https://www.mdpi.com/2227-9059/14/2/404
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!